ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.02
-0.02 (-0.33%)
Jan 30, 2026, 4:00 PM EST - Market closed
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $54.46 million as of January 30, 2026. Its market cap has increased by 15.51% in one year.
Market Cap
54.46M
Enterprise Value
64.18M
1-Year Change
15.51%
Ranking
Category
Stock Price
$6.02
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $54.46M, an increase of 2,633.74%. That is a compound annual growth rate of 10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 54.46M | -2.11% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 58.23M |
| TScan Therapeutics | 57.88M |
| Metagenomi Therapeutics | 57.82M |
| PMV Pharmaceuticals | 57.47M |
| Acrivon Therapeutics | 56.48M |
| Grace Therapeutics | 56.17M |
| MiNK Therapeutics | 55.30M |
| Alterity Therapeutics | 53.24M |